Trial Profile
Effect of Omega-3 Fatty Acids on Short and Long-Term Maintenance of Sinus Rhythm After Radiofrequency Catheter Ablation for Atrial Fibrillation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Arrhythmias; Atrial fibrillation
- Focus Therapeutic Use
- 24 Mar 2017 Status changed from completed to discontinued.
- 20 Jun 2013 New trial record